Gastrointestinal Therapeutics Market Size, Share & Trends Analysis Report By Drug Type, By Drug Class, By Route Of Administration, By Application, By Distribution Channel, By Region, And Segment Forecasts, 2026

The global gastrointestinal therapeutics market size was estimated at USD 42.75 billion in 2025 and is projected to reach USD 51.45 billion by 2033, growing at a CAGR of 2.2% from 2026 to 2033. The industry is expanding due to the rising incidence of digestive disorders across both developed and emerging regions.

The increasing prevalence of gastroesophageal reflux disease, irritable bowel syndrome, inflammatory bowel disease, and peptic ulcer disorders is strengthening the demand for long-term pharmacological management. Rapid urbanization, processed food consumption, irregular eating patterns, and elevated stress exposure are contributing to persistent gastrointestinal complications. A larger diagnosed patient population is seeking continuous symptom relief and disease control therapies. Higher consultation rates in primary and specialty care settings are further supporting prescription volumes.

Growing awareness regarding early symptom recognition is encouraging timely treatment initiation. For instance, in January 2026, Current Gastroenterology Reports, a Springer publication, reviewed acute severe ulcerative colitis and reported that intravenous corticosteroid therapy, used for about 70 years remained associated with colectomy rates of 25% to 30%, while severe flares occurred in 25% to 50% of patients during their disease course and 20% presented with a severe flare initially. The analysis further noted cumulative colectomy rates rising from 19.9% after the first admission to 38.6% after four admissions, and first year mortality of 40% to 75% in the pre steroid era, which declined to below 1% in the modern era, yet increased to about 5% in older or refractory cases, underscoring significant unmet clinical need.

Advancements in pharmaceutical research and product innovation are significantly contributing to market growth. Development of biologics, targeted small molecules, and improved acid suppression therapies is enhancing clinical outcomes for chronic gastrointestinal conditions. Novel drug delivery systems are improving absorption profiles and reducing adverse effects, strengthening patient adherence. Precision based treatment strategies are supporting individualized therapeutic regimens in inflammatory bowel disease and related disorders.

Global Gastrointestinal Therapeutics Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global gastrointestinal therapeutics market report based on drug type, drug class, route of administration, application, distribution channel, and region:

Drug Type Outlook (Revenue, USD Million, 2021 - 2033)
Branded
Generics
Drug Class Outlook (Revenue, USD Million, 2021 - 2033)
Aminosalicylates
Digestive Enzymes
Proton Pump Inhibitors
Laxatives
Anti-emetics
H2 Antagonists
Anti-diarrheals
Biologics/ Biosimilar
Others
Route of Administration Outlook (Revenue, USD Million, 2021 - 2033)
Oral
Injectables
Others
Application Outlook (Revenue, USD Million, 2021 - 2033)
Crohn's disease
Ulcerative colitis
GERD
IBS
Others
Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
Latin America
- Brazil
- Argentina
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait

Product Code: GVR-2-68038-338-6

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Drug Type
- 1.2.2. Drug Class
- 1.2.3. Route of Administration
- 1.2.4. Application
- 1.2.5. Distribution Channel
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
- 1.5.1. Purchased Database
- 1.5.2. GVR's Internal Database
- 1.5.3. Secondary Sources
- 1.5.4. Primary Research
1.6. Information Analysis
- 1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
- 1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Gastrointestinal Therapeutics Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
- 3.3.1. Industry Analysis - Porter's Five Forces Analysis
  - 3.3.1.1. Supplier Power
  - 3.3.1.2. Buyer Power
  - 3.3.1.3. Substitution Threat
  - 3.3.1.4. Threat of New Entrants
  - 3.3.1.5. Competitive Rivalry
- 3.3.2. PESTLE Analysis
- 3.3.3. Pipeline Analysis
- 3.3.4. Patent Expiry Analysis
- 3.3.5. Pricing Analysis

Chapter 4. Gastrointestinal Therapeutics Market: Drug Type Business Analysis

4.1. Drug Type Market Share, 2025 & 2033
4.2. Drug Type Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Drug Type, 2021 to 2033 (USD Million)
4.4. Branded
- 4.4.1. Branded Market, 2021 - 2033 (USD Million)
4.5. Generics
- 4.5.1. Generics Market, 2021 - 2033 (USD Million)

Chapter 5. Gastrointestinal Therapeutics Market: Drug Class Business Analysis

5.1. Drug Class Market Share, 2025 & 2033
5.2. Drug Class Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Drug class, 2021 to 2033 (USD Million)
5.4. Aminosalicylates
- 5.4.1. Aminosalicylates Market, 2021 - 2033 (USD Million)
5.5. Digestive Enzymes
- 5.5.1. Digestive Enzymes Market, 2021 - 2033 (USD Million)
5.6. Proton Pump Inhibitors
- 5.6.1. Proton Pump Inhibitors Market, 2021 - 2033 (USD Million)
5.7. Laxatives
- 5.7.1. Laxatives Market, 2021 - 2033 (USD Million)
5.8. Anti-emetics
- 5.8.1. Anti-emetics Market, 2021 - 2033 (USD Million)
5.9. H2 Antagonists
- 5.9.1. H2 Antagonists Market, 2021 - 2033 (USD Million)
5.10. Anti-diarrheals
- 5.10.1. Anti-diarrheals Market, 2021 - 2033 (USD Million)
5.11. Biologics/Biosimilar
- 5.11.1. Biologics/Biosimilar Market, 2021 - 2033 (USD Million)
5.12. Others
- 5.12.1. Others Market, 2021 - 2033 (USD Million)

Chapter 6. Gastrointestinal Therapeutics Market: Route of Administration Business Analysis

6.1. Route of Administration Market Share, 2025 & 2033
6.2. Route of Administration Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by Route of administration, 2021 to 2033 (USD Million)
6.4. Oral
- 6.4.1. Oral Market, 2021 - 2033 (USD Million)
6.5. Injectables
- 6.5.1. Injectables Market, 2021 - 2033 (USD Million)
6.6. Others
- 6.6.1. Others Market, 2021 - 2033 (USD Million)

Chapter 7. Gastrointestinal Therapeutics Market: Application Business Analysis

7.1. Application Market Share, 2025 & 2033
7.2. Application Segment Dashboard
7.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million)
7.4. Crohn's disease
- 7.4.1. Crohn's disease Market, 2021 - 2033 (USD Million)
7.5. Ulcerative colitis
- 7.5.1. Ulcerative colitis Market, 2021 - 2033 (USD Million)
7.6. GERD
- 7.6.1. GERD Market, 2021 - 2033 (USD Million)
7.7. IBS
- 7.7.1. IBS Market, 2021 - 2033 (USD Million)
7.8. Others
- 7.8.1. Others Market, 2021 - 2033 (USD Million)

Chapter 8. Gastrointestinal Therapeutics Market: Distribution Channel Business Analysis

8.1. Distribution Channel Market Share, 2025 & 2033
8.2. Distribution Channel Segment Dashboard
8.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
8.4. Hospital Pharmacies
- 8.4.1. Hospital Pharmacies Market, 2021 - 2033 (USD Million)
8.5. Retail Pharmacies
- 8.5.1. Retail Pharmacies Market, 2021 - 2033 (USD Million)
8.6. Online Pharmacies
- 8.6.1. Online Pharmacies Market, 2021 - 2033 (USD Million)

Chapter 9. Gastrointestinal Therapeutics Market: Regional Estimates & Trend Analysis

9.1. Regional Market Share Analysis, 2025 & 2033
9.2. Regional Market Dashboard
9.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
9.4. North America
- 9.4.1. North America Gastrointestinal Therapeutics Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
- 9.4.2. U.S.
  - 9.4.2.1. Key Country Dynamics
  - 9.4.2.2. Target Disease Prevalence
  - 9.4.2.3. Regulatory Framework
  - 9.4.2.4. Reimbursement Framework
  - 9.4.2.5. U.S. Gastrointestinal Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.4.3. Canada
  - 9.4.3.1. Key Country Dynamics
  - 9.4.3.2. Target Disease Prevalence
  - 9.4.3.3. Regulatory Framework
  - 9.4.3.4. Reimbursement Framework
  - 9.4.3.5. Canada Gastrointestinal Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.4.4. Mexico
  - 9.4.4.1. Key Country Dynamics
  - 9.4.4.2. Target Disease Prevalence
  - 9.4.4.3. Regulatory Framework
  - 9.4.4.4. Reimbursement Framework
  - 9.4.4.5. Mexico Gastrointestinal Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.5. Europe
- 9.5.1. Europe Gastrointestinal Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.5.2. UK
  - 9.5.2.1. Key Country Dynamics
  - 9.5.2.2. Target Disease Prevalence
  - 9.5.2.3. Regulatory Framework
  - 9.5.2.4. Reimbursement Framework
  - 9.5.2.5. UK Gastrointestinal Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.5.3. Germany
  - 9.5.3.1. Key Country Dynamics
  - 9.5.3.2. Target Disease Prevalence
  - 9.5.3.3. Regulatory Framework
  - 9.5.3.4. Reimbursement Framework
  - 9.5.3.5. Germany Gastrointestinal Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.5.4. France
  - 9.5.4.1. Key Country Dynamics
  - 9.5.4.2. Target Disease Prevalence
  - 9.5.4.3. Regulatory Framework
  - 9.5.4.4. Reimbursement Framework
  - 9.5.4.5. France Gastrointestinal Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.5.5. Italy
  - 9.5.5.1. Key Country Dynamics
  - 9.5.5.2. Target Disease Prevalence
  - 9.5.5.3. Regulatory Framework
  - 9.5.5.4. Reimbursement Framework
  - 9.5.5.5. Italy Gastrointestinal Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.5.6. Spain
  - 9.5.6.1. Key Country Dynamics
  - 9.5.6.2. Target Disease Prevalence
  - 9.5.6.3. Regulatory Framework
  - 9.5.6.4. Reimbursement Framework
  - 9.5.6.5. Spain Gastrointestinal Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.5.7. Denmark
  - 9.5.7.1. Key Country Dynamics
  - 9.5.7.2. Target Disease Prevalence
  - 9.5.7.3. Regulatory Framework
  - 9.5.7.4. Reimbursement Framework
  - 9.5.7.5. Denmark Gastrointestinal Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.5.8. Sweden
  - 9.5.8.1. Key Country Dynamics
  - 9.5.8.2. Target Disease Prevalence
  - 9.5.8.3. Regulatory Framework
  - 9.5.8.4. Reimbursement Framework
  - 9.5.8.5. Sweden Gastrointestinal Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.5.9. Norway
  - 9.5.9.1. Key Country Dynamics
  - 9.5.9.2. Target Disease Prevalence
  - 9.5.9.3. Regulatory Framework
  - 9.5.9.4. Reimbursement Framework
  - 9.5.9.5. Norway Gastrointestinal Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.6. Asia Pacific
- 9.6.1. Asia Pacific Gastrointestinal Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.6.2. Japan
  - 9.6.2.1. Key Country Dynamics
  - 9.6.2.2. Target Disease Prevalence
  - 9.6.2.3. Regulatory Framework
  - 9.6.2.4. Reimbursement Framework
  - 9.6.2.5. Japan Gastrointestinal Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.6.3. China
  - 9.6.3.1. Key Country Dynamics
  - 9.6.3.2. Target Disease Prevalence
  - 9.6.3.3. Regulatory Framework
  - 9.6.3.4. Reimbursement Framework
  - 9.6.3.5. China Gastrointestinal Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.6.4. India
  - 9.6.4.1. Key Country Dynamics
  - 9.6.4.2. Target Disease Prevalence
  - 9.6.4.3. Regulatory Framework
  - 9.6.4.4. Reimbursement Framework
  - 9.6.4.5. India Gastrointestinal Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.6.5. Australia
  - 9.6.5.1. Key Country Dynamics
  - 9.6.5.2. Target Disease Prevalence
  - 9.6.5.3. Regulatory Framework
  - 9.6.5.4. Reimbursement Framework
  - 9.6.5.5. Australia Gastrointestinal Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.6.6. South Korea
  - 9.6.6.1. Key Country Dynamics
  - 9.6.6.2. Target Disease Prevalence
  - 9.6.6.3. Regulatory Framework
  - 9.6.6.4. Reimbursement Framework
  - 9.6.6.5. South Korea Gastrointestinal Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.6.7. Thailand
  - 9.6.7.1. Key Country Dynamics
  - 9.6.7.2. Target Disease Prevalence
  - 9.6.7.3. Regulatory Framework
  - 9.6.7.4. Reimbursement Framework
  - 9.6.7.5. Thailand Gastrointestinal Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.7. Latin America
- 9.7.1. Latin America Gastrointestinal Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.7.2. Brazil
  - 9.7.2.1. Key Country Dynamics
  - 9.7.2.2. Target Disease Prevalence
  - 9.7.2.3. Regulatory Framework
  - 9.7.2.4. Reimbursement Framework
  - 9.7.2.5. Brazil Gastrointestinal Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.7.3. Argentina
  - 9.7.3.1. Key Country Dynamics
  - 9.7.3.2. Target Disease Prevalence
  - 9.7.3.3. Regulatory Framework
  - 9.7.3.4. Reimbursement Framework
  - 9.7.3.5. Argentina Gastrointestinal Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.8. Middle East and Africa
- 9.8.1. Middle East and Africa Gastrointestinal Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.8.2. South Africa
  - 9.8.2.1. Key Country Dynamics
  - 9.8.2.2. Target Disease Prevalence
  - 9.8.2.3. Regulatory Framework
  - 9.8.2.4. Reimbursement Framework
  - 9.8.2.5. South Africa Gastrointestinal Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.8.3. Saudi Arabia
  - 9.8.3.1. Key Country Dynamics
  - 9.8.3.2. Target Disease Prevalence
  - 9.8.3.3. Regulatory Framework
  - 9.8.3.4. Reimbursement Framework
  - 9.8.3.5. Saudi Arabia Gastrointestinal Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.8.4. UAE
  - 9.8.4.1. Key Country Dynamics
  - 9.8.4.2. Target Disease Prevalence
  - 9.8.4.3. Regulatory Framework
  - 9.8.4.4. Reimbursement Framework
  - 9.8.4.5. UAE Gastrointestinal Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.8.5. Kuwait
  - 9.8.5.1. Key Country Dynamics
  - 9.8.5.2. Target Disease Prevalence
  - 9.8.5.3. Regulatory Framework
  - 9.8.5.4. Reimbursement Framework
  - 9.8.5.5. Kuwait Gastrointestinal Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

10.1. Participant Overview
10.2. Company Market Position Analysis
10.3. Company Categorization
10.4. Strategy Mapping
10.5. Company Profiles/Listing
- 10.5.1. AbbVie Inc.
  - 10.5.1.1. Overview
  - 10.5.1.2. Financial Performance
  - 10.5.1.3. Product Benchmarking
  - 10.5.1.4. Strategic Initiatives
- 10.5.2. AstraZeneca
  - 10.5.2.1. Overview
  - 10.5.2.2. Financial Performance
  - 10.5.2.3. Product Benchmarking
  - 10.5.2.4. Strategic Initiatives
- 10.5.3. Salix Pharmaceuticals
  - 10.5.3.1. Overview
  - 10.5.3.2. Financial Performance
  - 10.5.3.3. Product Benchmarking
  - 10.5.3.4. Strategic Initiatives
- 10.5.4. Takeda Pharmaceutical Company Limited
  - 10.5.4.1. Overview
  - 10.5.4.2. Financial Performance
  - 10.5.4.3. Product Benchmarking
  - 10.5.4.4. Strategic Initiatives
- 10.5.5. Pfizer Inc.
  - 10.5.5.1. Overview
  - 10.5.5.2. Financial Performance
  - 10.5.5.3. Product Benchmarking
  - 10.5.5.4. Strategic Initiatives
- 10.5.6. Bayer AG
  - 10.5.6.1. Overview
  - 10.5.6.2. Financial Performance
  - 10.5.6.3. Product Benchmarking
  - 10.5.6.4. Strategic Initiatives
- 10.5.7. Abbott
  - 10.5.7.1. Overview
  - 10.5.7.2. Financial Performance
  - 10.5.7.3. Product Benchmarking
  - 10.5.7.4. Strategic Initiatives
- 10.5.8. Janssen Pharmaceuticals NV
  - 10.5.8.1. Overview
  - 10.5.8.2. Financial Performance
  - 10.5.8.3. Product Benchmarking
  - 10.5.8.4. Strategic Initiatives
- 10.5.9. Sun Pharmaceutical Industries Ltd.
  - 10.5.9.1. Overview
  - 10.5.9.2. Financial Performance
  - 10.5.9.3. Product Benchmarking
  - 10.5.9.4. Strategic Initiatives
- 10.5.10. Cipla Inc.
  - 10.5.10.1. Overview
  - 10.5.10.2. Financial Performance
  - 10.5.10.3. Product Benchmarking
  - 10.5.10.4. Strategic Initiatives
- 10.5.11. Gilead Sciences, Inc.
  - 10.5.11.1. Overview
  - 10.5.11.2. Financial Performance
  - 10.5.11.3. Product Benchmarking
  - 10.5.11.4. Strategic Initiatives

Product Code: GVR-2-68038-338-6

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global gastrointestinal therapeutics market, by region, 2021 - 2033 (USD Million)
Table 4 Global gastrointestinal therapeutics market, by drug type, 2021 - 2033 (USD Million)
Table 5 Global gastrointestinal therapeutics market, by drug class, 2021 - 2033 (USD Million)
Table 6 Global gastrointestinal therapeutics market, by route of administration, 2021 - 2033 (USD Million)
Table 7 Global gastrointestinal therapeutics market, by application, 2021 - 2033 (USD Million)
Table 8 Global gastrointestinal therapeutics market, by distribution channel, 2021 - 2033 (USD Million)
Table 9 North America gastrointestinal therapeutics market, by country, 2021 - 2033 (USD Million)
Table 10 North America gastrointestinal therapeutics market, by drug type, 2021 - 2033 (USD Million)
Table 11 North America gastrointestinal therapeutics market, by drug class, 2021 - 2033 (USD Million)
Table 12 North America gastrointestinal therapeutics market, by route of administration, 2021 - 2033 (USD Million)
Table 13 North America gastrointestinal therapeutics market, by application, 2021 - 2033 (USD Million)
Table 14 North America gastrointestinal therapeutics market, by distribution channel, 2021 - 2033 (USD Million)
Table 15 U.S. gastrointestinal therapeutics market, by drug type, 2021 - 2033 (USD Million)
Table 16 U.S. gastrointestinal therapeutics market, by drug class, 2021 - 2033 (USD Million)
Table 17 U.S. gastrointestinal therapeutics market, by route of administration, 2021 - 2033 (USD Million)
Table 18 U.S. gastrointestinal therapeutics market, by application, 2021 - 2033 (USD Million)
Table 19 U.S. gastrointestinal therapeutics market, by distribution channel, 2021 - 2033 (USD Million)
Table 20 Canada gastrointestinal therapeutics market, by drug type, 2021 - 2033 (USD Million)
Table 21 Canada gastrointestinal therapeutics market, by drug class, 2021 - 2033 (USD Million)
Table 22 Canada gastrointestinal therapeutics market, by route of administration, 2021 - 2033 (USD Million)
Table 23 Canada gastrointestinal therapeutics market, by application, 2021 - 2033 (USD Million)
Table 24 Canada gastrointestinal therapeutics market, by distribution channel, 2021 - 2033 (USD Million)
Table 25 Mexico gastrointestinal therapeutics market, by drug type, 2021 - 2033 (USD Million)
Table 26 Mexico gastrointestinal therapeutics market, by drug class, 2021 - 2033 (USD Million)
Table 27 Mexico gastrointestinal therapeutics market, by route of administration, 2021 - 2033 (USD Million)
Table 28 Mexico gastrointestinal therapeutics market, by application, 2021 - 2033 (USD Million)
Table 29 Mexico gastrointestinal therapeutics market, by distribution channel, 2021 - 2033 (USD Million)
Table 30 Europe gastrointestinal therapeutics market, by country, 2021 - 2033 (USD Million)
Table 31 Europe gastrointestinal therapeutics market, by drug type, 2021 - 2033 (USD Million)
Table 32 Europe gastrointestinal therapeutics market, by drug class, 2021 - 2033 (USD Million)
Table 33 Europe gastrointestinal therapeutics market, by route of administration, 2021 - 2033 (USD Million)
Table 34 Europe gastrointestinal therapeutics market, by application, 2021 - 2033 (USD Million)
Table 35 Europe gastrointestinal therapeutics market, by distribution channel, 2021 - 2033 (USD Million)
Table 36 UK gastrointestinal therapeutics market, by drug type, 2021 - 2033 (USD Million)
Table 37 UK gastrointestinal therapeutics market, by drug class, 2021 - 2033 (USD Million)
Table 38 UK gastrointestinal therapeutics market, by route of administration, 2021 - 2033 (USD Million)
Table 39 UK gastrointestinal therapeutics market, by application, 2021 - 2033 (USD Million)
Table 40 UK gastrointestinal therapeutics market, by distribution channel, 2021 - 2033 (USD Million)
Table 41 Germany gastrointestinal therapeutics market, by drug type, 2021 - 2033 (USD Million)
Table 42 Germany gastrointestinal therapeutics market, by drug class, 2021 - 2033 (USD Million)
Table 43 Germany gastrointestinal therapeutics market, by route of administration, 2021 - 2033 (USD Million)
Table 44 Germany gastrointestinal therapeutics market, by application, 2021 - 2033 (USD Million)
Table 45 Germany gastrointestinal therapeutics market, by distribution channel, 2021 - 2033 (USD Million)
Table 46 France gastrointestinal therapeutics market, by drug type, 2021 - 2033 (USD Million)
Table 47 France gastrointestinal therapeutics market, by drug class, 2021 - 2033 (USD Million)
Table 48 France gastrointestinal therapeutics market, by route of administration, 2021 - 2033 (USD Million)
Table 49 France gastrointestinal therapeutics market, by application, 2021 - 2033 (USD Million)
Table 50 France gastrointestinal therapeutics market, by distribution channel, 2021 - 2033 (USD Million)
Table 51 Italy gastrointestinal therapeutics market, by drug type, 2021 - 2033 (USD Million)
Table 52 Italy gastrointestinal therapeutics market, by drug class, 2021 - 2033 (USD Million)
Table 53 Italy gastrointestinal therapeutics market, by route of administration, 2021 - 2033 (USD Million)
Table 54 Italy gastrointestinal therapeutics market, by application, 2021 - 2033 (USD Million)
Table 55 Italy gastrointestinal therapeutics market, by distribution channel, 2021 - 2033 (USD Million)
Table 56 Spain gastrointestinal therapeutics market, by drug type, 2021 - 2033 (USD Million)
Table 57 Spain gastrointestinal therapeutics market, by drug class, 2021 - 2033 (USD Million)
Table 58 Spain gastrointestinal therapeutics market, by route of administration, 2021 - 2033 (USD Million)
Table 59 Spain gastrointestinal therapeutics market, by application, 2021 - 2033 (USD Million)
Table 60 Spain gastrointestinal therapeutics market, by distribution channel, 2021 - 2033 (USD Million)
Table 61 Norway gastrointestinal therapeutics market, by drug type, 2021 - 2033 (USD Million)
Table 62 Norway gastrointestinal therapeutics market, by drug class, 2021 - 2033 (USD Million)
Table 63 Norway gastrointestinal therapeutics market, by route of administration, 2021 - 2033 (USD Million)
Table 64 Norway gastrointestinal therapeutics market, by application, 2021 - 2033 (USD Million)
Table 65 Norway gastrointestinal therapeutics market, by distribution channel, 2021 - 2033 (USD Million)
Table 66 Denmark gastrointestinal therapeutics market, by drug type, 2021 - 2033 (USD Million)
Table 67 Denmark gastrointestinal therapeutics market, by drug class, 2021 - 2033 (USD Million)
Table 68 Denmark gastrointestinal therapeutics market, by route of administration, 2021 - 2033 (USD Million)
Table 69 Global gastrointestinal therapeutics market, by application, 2021 - 2033 (USD Million)
Table 70 Global gastrointestinal therapeutics market, by distribution channel, 2021 - 2033 (USD Million)
Table 71 Sweden gastrointestinal therapeutics market, by drug type, 2021 - 2033 (USD Million)
Table 72 Sweden gastrointestinal therapeutics market, by drug class, 2021 - 2033 (USD Million)
Table 73 Sweden gastrointestinal therapeutics market, by route of administration, 2021 - 2033 (USD Million)
Table 74 Sweden gastrointestinal therapeutics market, by application, 2021 - 2033 (USD Million)
Table 75 Sweden gastrointestinal therapeutics market, by distribution channel, 2021 - 2033 (USD Million)
Table 76 Asia Pacific gastrointestinal therapeutics market, by country, 2021 - 2033 (USD Million)
Table 77 Asia Pacific gastrointestinal therapeutics market, by drug type, 2021 - 2033 (USD Million)
Table 78 Asia Pacific gastrointestinal therapeutics market, by drug class, 2021 - 2033 (USD Million)
Table 79 Asia Pacific gastrointestinal therapeutics market, by route of administration, 2021 - 2033 (USD Million)
Table 80 Asia Pacific gastrointestinal therapeutics market, by application, 2021 - 2033 (USD Million)
Table 81 Asia Pacific gastrointestinal therapeutics market, by distribution channel, 2021 - 2033 (USD Million)
Table 82 Japan gastrointestinal therapeutics market, by drug type, 2021 - 2033 (USD Million)
Table 83 Japan gastrointestinal therapeutics market, by drug class, 2021 - 2033 (USD Million)
Table 84 Japan gastrointestinal therapeutics market, by route of administration, 2021 - 2033 (USD Million)
Table 85 Japan gastrointestinal therapeutics market, by application, 2021 - 2033 (USD Million)
Table 86 Japan gastrointestinal therapeutics market, by distribution channel, 2021 - 2033 (USD Million)
Table 87 China gastrointestinal therapeutics market, by drug type, 2021 - 2033 (USD Million)
Table 88 China gastrointestinal therapeutics market, by drug class, 2021 - 2033 (USD Million)
Table 89 China gastrointestinal therapeutics market, by route of administration, 2021 - 2033 (USD Million)
Table 90 China gastrointestinal therapeutics market, by application, 2021 - 2033 (USD Million)
Table 91 China gastrointestinal therapeutics market, by distribution channel, 2021 - 2033 (USD Million)
Table 92 India gastrointestinal therapeutics market, by drug type, 2021 - 2033 (USD Million)
Table 93 India gastrointestinal therapeutics market, by drug class, 2021 - 2033 (USD Million)
Table 94 India gastrointestinal therapeutics market, by route of administration, 2021 - 2033 (USD Million)
Table 95 India gastrointestinal therapeutics market, by application, 2021 - 2033 (USD Million)
Table 96 India gastrointestinal therapeutics market, by distribution channel, 2021 - 2033 (USD Million)
Table 97 Australia gastrointestinal therapeutics market, by drug type, 2021 - 2033 (USD Million)
Table 98 Australia gastrointestinal therapeutics market, by drug class, 2021 - 2033 (USD Million)
Table 99 Australia gastrointestinal therapeutics market, by route of administration, 2021 - 2033 (USD Million)
Table 100 Australia gastrointestinal therapeutics market, by application, 2021 - 2033 (USD Million)
Table 101 Australia gastrointestinal therapeutics market, by distribution channel, 2021 - 2033 (USD Million)
Table 102 South Korea gastrointestinal therapeutics market, by drug type, 2021 - 2033 (USD Million)
Table 103 South Korea gastrointestinal therapeutics market, by drug class, 2021 - 2033 (USD Million)
Table 104 South Korea gastrointestinal therapeutics market, by route of administration, 2021 - 2033 (USD Million)
Table 105 South Korea gastrointestinal therapeutics market, by application, 2021 - 2033 (USD Million)
Table 106 South Korea gastrointestinal therapeutics market, by distribution channel, 2021 - 2033 (USD Million)
Table 107 Thailand gastrointestinal therapeutics market, by drug type, 2021 - 2033 (USD Million)
Table 108 Thailand gastrointestinal therapeutics market, by drug class, 2021 - 2033 (USD Million)
Table 109 Thailand gastrointestinal therapeutics market, by route of administration, 2021 - 2033 (USD Million)
Table 110 Thailand gastrointestinal therapeutics market, by application, 2021 - 2033 (USD Million)
Table 111 Thailand gastrointestinal therapeutics market, by distribution channel, 2021 - 2033 (USD Million)
Table 112 Latin America gastrointestinal therapeutics market, by country, 2021 - 2033 (USD Million)
Table 113 Latin America gastrointestinal therapeutics market, by drug type, 2021 - 2033 (USD Million)
Table 114 Latin America gastrointestinal therapeutics market, by drug class, 2021 - 2033 (USD Million)
Table 115 Latin America gastrointestinal therapeutics market, by route of administration, 2021 - 2033 (USD Million)
Table 116 Latin America gastrointestinal therapeutics market, by application, 2021 - 2033 (USD Million)
Table 117 Latin America gastrointestinal therapeutics market, by distribution channel, 2021 - 2033 (USD Million)
Table 118 Brazil gastrointestinal therapeutics market, by drug type, 2021 - 2033 (USD Million)
Table 119 Brazil gastrointestinal therapeutics market, by drug class, 2021 - 2033 (USD Million)
Table 120 Brazil gastrointestinal therapeutics market, by route of administration, 2021 - 2033 (USD Million)
Table 121 Brazil gastrointestinal therapeutics market, by application, 2021 - 2033 (USD Million)
Table 122 Brazil gastrointestinal therapeutics market, by distribution channel, 2021 - 2033 (USD Million)
Table 123 Argentina gastrointestinal therapeutics market, by drug type, 2021 - 2033 (USD Million)
Table 124 Argentina gastrointestinal therapeutics market, by drug class, 2021 - 2033 (USD Million)
Table 125 Argentina gastrointestinal therapeutics market, by route of administration, 2021 - 2033 (USD Million)
Table 126 Argentina gastrointestinal therapeutics market, by application, 2021 - 2033 (USD Million)
Table 127 Argentina gastrointestinal therapeutics market, by distribution channel, 2021 - 2033 (USD Million)
Table 128 Middle East & Africa gastrointestinal therapeutics market, by country, 2021 - 2033 (USD Million)
Table 129 Middle East & Africa gastrointestinal therapeutics market, by drug type, 2021 - 2033 (USD Million)
Table 130 Middle East & Africa gastrointestinal therapeutics market, by drug class, 2021 - 2033 (USD Million)
Table 131 Middle East & Africa gastrointestinal therapeutics market, by route of administration, 2021 - 2033 (USD Million)
Table 132 Middle East & Africa gastrointestinal therapeutics market, by application, 2021 - 2033 (USD Million)
Table 133 Middle East & Africa gastrointestinal therapeutics market, by distribution channel, 2021 - 2033 (USD Million)
Table 134 South Africa gastrointestinal therapeutics market, by drug type, 2021 - 2033 (USD Million)
Table 135 South Africa gastrointestinal therapeutics market, by drug class, 2021 - 2033 (USD Million)
Table 136 South Africa gastrointestinal therapeutics market, by route of administration, 2021 - 2033 (USD Million)
Table 137 South Africa gastrointestinal therapeutics market, by application, 2021 - 2033 (USD Million)
Table 138 South Africa gastrointestinal therapeutics market, by distribution channel, 2021 - 2033 (USD Million)
Table 139 Saudi Arabia gastrointestinal therapeutics market, by drug type, 2021 - 2033 (USD Million)
Table 140 Saudi Arabia gastrointestinal therapeutics market, by drug class, 2021 - 2033 (USD Million)
Table 141 Saudi Arabia gastrointestinal therapeutics market, by route of administration, 2021 - 2033 (USD Million)
Table 142 Saudi Arabia gastrointestinal therapeutics market, by application, 2021 - 2033 (USD Million)
Table 143 Saudi Arabia gastrointestinal therapeutics market, by distribution channel, 2021 - 2033 (USD Million)
Table 144 UAE gastrointestinal therapeutics market, by drug type, 2021 - 2033 (USD Million)
Table 145 UAE gastrointestinal therapeutics market, by drug class, 2021 - 2033 (USD Million)
Table 146 UAE gastrointestinal therapeutics market, by route of administration, 2021 - 2033 (USD Million)
Table 147 UAE gastrointestinal therapeutics market, by application, 2021 - 2033 (USD Million)
Table 148 UAE gastrointestinal therapeutics market, by distribution channel, 2021 - 2033 (USD Million)
Table 149 Kuwait gastrointestinal therapeutics market, by drug type, 2021 - 2033 (USD Million)
Table 150 Kuwait gastrointestinal therapeutics market, by drug class, 2021 - 2033 (USD Million)
Table 151 Kuwait gastrointestinal therapeutics market, by route of administration, 2021 - 2033 (USD Million)
Table 152 Kuwait gastrointestinal therapeutics market, by application, 2021 - 2033 (USD Million)
Table 153 Kuwait gastrointestinal therapeutics market, by distribution channel, 2021 - 2033 (USD Million)

List of Figures

Fig. 1 Gastrointestinal Therapeutics Market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Competitive landscape
Fig. 10 Gastrointestinal Therapeutics Market dynamics
Fig. 11 Gastrointestinal Therapeutics Market: Porter's five forces analysis
Fig. 12 Gastrointestinal Therapeutics Market: PESTLE analysis
Fig. 13 Drug type market, 2021 - 2033 (USD Million)
Fig. 14 Branded market, 2021 - 2033 (USD Million)
Fig. 15 Generics market, 2021 - 2033 (USD Million)
Fig. 16 Drug class market, 2021 - 2033 (USD Million)
Fig. 17 Aminosalicylates market, 2021 - 2033 (USD Million)
Fig. 18 Digestive Enzymes market, 2021 - 2033 (USD Million)
Fig. 19 Proton Pump Inhibitors market, 2021 - 2033 (USD Million)
Fig. 20 Laxatives market, 2021 - 2033 (USD Million)
Fig. 21 Anti-emetics market, 2021 - 2033 (USD Million)
Fig. 22 H2 Antagonists market, 2021 - 2033 (USD Million)
Fig. 23 Anti-diarrheals market, 2021 - 2033 (USD Million)
Fig. 24 Biologics/Biosimilar market, 2021 - 2033 (USD Million)
Fig. 25 Others market, 2021 - 2033 (USD Million)
Fig. 26 Route of Administration market, 2021 - 2033 (USD Million)
Fig. 27 Oral market, 2021 - 2033 (USD Million)
Fig. 28 Injectables market, 2021 - 2033 (USD Million)
Fig. 29 Others market, 2021 - 2033 (USD Million)
Fig. 30 Application market, 2021 - 2033 (USD Million)
Fig. 31 Crohn's disease market, 2021 - 2033 (USD Million)
Fig. 32 Ulcerative colitis market, 2021 - 2033 (USD Million)
Fig. 33 GERD market, 2021 - 2033 (USD Million)
Fig. 34 IBS market, 2021 - 2033 (USD Million)
Fig. 35 Others market, 2021 - 2033 (USD Million)
Fig. 36 Distribution Channel market, 2021 - 2033 (USD Million)
Fig. 37 Hospital Pharmacies market, 2021 - 2033 (USD Million)
Fig. 38 Retail Pharmacies market, 2021 - 2033 (USD Million)
Fig. 39 Online Pharmacies market, 2021 - 2033 (USD Million)
Fig. 40 Gastrointestinal Therapeutics Market revenue, by region
Fig. 41 Regional marketplace: Key takeaways
Fig. 42 North America Gastrointestinal Therapeutics Market, 2021 - 2033 (USD Million)
Fig. 43 U.S. country dynamics
Fig. 44 U.S. Gastrointestinal Therapeutics Market, 2021 - 2033 (USD Million)
Fig. 45 Canada country dynamics
Fig. 46 Canada Gastrointestinal Therapeutics Market, 2021 - 2033 (USD Million)
Fig. 47 Mexico country dynamics
Fig. 48 Mexico Gastrointestinal Therapeutics Market, 2021 - 2033 (USD Million)
Fig. 49 Europe Gastrointestinal Therapeutics Market, 2021 - 2033 (USD Million)
Fig. 50 UK country dynamics
Fig. 51 UK Gastrointestinal Therapeutics Market, 2021 - 2033 (USD Million)
Fig. 52 Germany country dynamics
Fig. 53 Germany Gastrointestinal Therapeutics Market, 2021 - 2033 (USD Million)
Fig. 54 France country dynamics
Fig. 55 France Gastrointestinal Therapeutics Market, 2021 - 2033 (USD Million)
Fig. 56 Italy country dynamics
Fig. 57 Italy Gastrointestinal Therapeutics Market, 2021 - 2033 (USD Million)
Fig. 58 Spain country dynamics
Fig. 59 Spain Gastrointestinal Therapeutics Market, 2021 - 2033 (USD Million)
Fig. 60 Norway country dynamics
Fig. 61 Norway Gastrointestinal Therapeutics Market, 2021 - 2033 (USD Million)
Fig. 62 Sweden country dynamics
Fig. 63 Sweden Gastrointestinal Therapeutics Market, 2021 - 2033 (USD Million)
Fig. 64 Denmark country dynamics
Fig. 65 Denmark Gastrointestinal Therapeutics Market, 2021 - 2033 (USD Million)
Fig. 66 Asia Pacific Gastrointestinal Therapeutics Market, 2021 - 2033 (USD Million)
Fig. 67 Japan country dynamics
Fig. 68 Japan Gastrointestinal Therapeutics Market, 2021 - 2033 (USD Million)
Fig. 69 China country dynamics
Fig. 70 China Gastrointestinal Therapeutics Market, 2021 - 2033 (USD Million)
Fig. 71 India country dynamics
Fig. 72 India Gastrointestinal Therapeutics Market, 2021 - 2033 (USD Million)
Fig. 73 Australia country dynamics
Fig. 74 Australia Gastrointestinal Therapeutics Market, 2021 - 2033 (USD Million)
Fig. 75 South Korea country dynamics
Fig. 76 South Korea Gastrointestinal Therapeutics Market, 2021 - 2033 (USD Million)
Fig. 77 Thailand country dynamics
Fig. 78 Thailand Gastrointestinal Therapeutics Market, 2021 - 2033 (USD Million)
Fig. 79 Latin America Gastrointestinal Therapeutics Market, 2021 - 2033 (USD Million)
Fig. 80 Brazil country dynamics
Fig. 81 Brazil Gastrointestinal Therapeutics Market, 2021 - 2033 (USD Million)
Fig. 82 Argentina country dynamics
Fig. 83 Argentina Gastrointestinal Therapeutics Market, 2021 - 2033 (USD Million)
Fig. 84 MEA Gastrointestinal Therapeutics Market, 2021 - 2033 (USD Million)
Fig. 85 South Africa country dynamics
Fig. 86 South Africa Gastrointestinal Therapeutics Market, 2021 - 2033 (USD Million)
Fig. 87 Saudi Arabia country dynamics
Fig. 88 Saudi Arabia Gastrointestinal Therapeutics Market, 2021 - 2033 (USD Million)
Fig. 89 UAE country dynamics
Fig. 90 UAE Gastrointestinal Therapeutics Market, 2021 - 2033 (USD Million)
Fig. 91 Kuwait country dynamics
Fig. 92 Kuwait Gastrointestinal Therapeutics Market, 2021 - 2033 (USD Million)
Fig. 93 Company categorization
Fig. 94 Company market position analysis
Fig. 95 Strategic framework

Gastrointestinal Therapeutics Market Size, Share & Trends Analysis Report By Drug Type, By Drug Class, By Route Of Administration, By Application, By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033

Description

Table of Contents

List of Tables

Gastrointestinal Therapeutics Market Summary

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Gastrointestinal Therapeutics Market Variables, Trends, & Scope

Chapter 4. Gastrointestinal Therapeutics Market: Drug Type Business Analysis

Chapter 5. Gastrointestinal Therapeutics Market: Drug Class Business Analysis

Chapter 6. Gastrointestinal Therapeutics Market: Route of Administration Business Analysis

Chapter 7. Gastrointestinal Therapeutics Market: Application Business Analysis

Chapter 8. Gastrointestinal Therapeutics Market: Distribution Channel Business Analysis

Chapter 9. Gastrointestinal Therapeutics Market: Regional Estimates & Trend Analysis

Chapter 10. Competitive Landscape

List of Tables

List of Figures